Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Russian Medtech Industry Wants Quicker Progress On Eurasian Bloc Plans – 2017 Now Targeted

Executive Summary

The much-anticipated Eurasian Economic Union (EAEU) was originally targeted to come into effect at the start of 2016, but more than year later, the five-member trading bloc has yet to be ratified by all nations. The Russian medtech industry is impatient for progress, but IMEDA's Sergey Kolosov sees some promising signs in recent developments.

Advertisement

Related Content

QMS And Lab Accreditations Allow Russian Regulator To Green Light Eurasian Device System
Eurasian Union For Medtech Gathers Pace, But Barriers Hamper Timely Completion
Eurasian Medtech Agreement Clears Key Thresholds
Russian Icebreaker: IMEDA Seeks To Keep Medtech Channels Open
Russia's Medtech Looks For Chain Reaction After Philips Partnership Deal
Flurry of Russian Medtech Regulatory System Proposals Keeps Manufacturers On Their Toes

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT104482

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel